The frequency of targetable alterations was roughly 22% in patients of African ancestry and those of European ancestry. Rates of actionable genetic alterations were similar in prostate cancer patients ...
Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer Low-pass whole-genome and targeted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback